Heparin-like saccharides play an essential role in binding to both fibroblast growth factors (FGF) and their receptors at the cell surface. In this study we prepared a series of heparin oligosaccharides according to their size and sulfation level. We then investigated their affinity for FGF2 and their ability to support FGF2 mitogenesis of heparan sulfate-deficient cells expressing FGFR1c. Tetra-and hexasaccharides bound FGF2, but failed to dimerize the growth factor. Nevertheless, these saccharides promoted FGF2-mediated cell growth. Furthermore, whereas enzymatic removal of the non-reducing end 2-O-sulfate group had little effect on the 1:1 interaction with FGF2, it eliminated the mitogenic activity of these saccharides. This evidence supports the symmetric two-end model of ternary complex formation. In contrast, even at very low concentrations, octasaccharide and larger heparin fragments conferred a potent mitogenic activity that was independent of terminal 2-O-sulfation. This correlated with the ability to dimerize FGF2 in an apparently cooperative manner. This data suggests that potent mitogenic signaling results from heparin-mediated trans-dimerization of FGF2, consistent with the asymmetric model of ternary complex formation. We propose that, depending on saccharide structure, there are different architectures and modes of ternary complex assembly that differ in stability and/or efficiency of transmembrane signaling.FGF1 and FGF2 are the prototypic members of the fibroblast growth factor (FGF) 3 family. They can induce proliferation, differentiation, motility, adhesion, survival, and apoptosis of cells at both embryonic and adult stages (1, 2). A wide variety of cells express FGF1 and FGF2, for example, vascular smooth muscle cells, neurons, epithelial cells, and fibroblasts (3). FGF2 can also be released by macrophages in response to inflammation (4) or by platelets in response to vessel injury (5). FGF1 and FGF2 are potent angiogenic factors (6). Angiogenesis, the formation of new blood vessels, is important in human disease; it is induced by malignant tumors, and is a cause of arthritis and visual impairment in diabetic retinopathies. Tumors secrete pro-angiogenic molecules, such as the FGFs, in an autocrine or paracrine manner, and increased FGF levels are associated with poor prognosis for many cancers (2, 7).Heparan sulfate (HS) proteoglycans are membrane-associated co-receptors that coordinate the interaction of FGFs with their high-affinity tyrosine kinase receptors, the FGFRs (8). These high-affinity receptors are the products of distinct mammalian genes: FGFR1 (flg), FGFR2 (bek), FGFR3, and FGFR4. FGFR1-3 can be alternatively spliced to produce a, b, and c isoforms. The a isoform is secreted and may function as a soluble receptor antagonist (9). The b and c receptor variants are particularly important as they display different ligand binding specificities and affinities (10). For example, FGFR2c was reported to bind FGF1 and FGF2 with equal affinity, whereas FGFR2b bound FGF2 with a thousand-fol...